Testing effectiveness (Phase 2)Ended earlyNCT02669914
What this trial is testing
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more
Washington University School of Medicine 4